Managing AI Platforms for Healthcare — Governance, Assessment, and Operational Challenges
CONCEPTSignal 1 CEO Tomi Poutanen has discussed LLM performance assessment for healthcare AI platforms with the Derby Mill/IntrepidGP team, as published in IntrepidGP Healthcare AI Episode 27. The conversation addresses the practical challenge of evaluating LLM performance in healthcare contexts where standard benchmarks may not capture clinically relevant performance dimensions. Managing AI platforms for healthcare requires ongoing assessment rather than one-time validation. LLMs deployed in clinical settings may drift in performance over time as underlying models are updated, as clinical workflows change, or as patient populations shift. Governance frameworks must include continuous monitoring mechanisms, not just pre-deployment evaluation. Signal 1's AIMS platform, referenced in the NewYork-Presbyterian governance context, represents one approach to ongoing AI performance monitoring in healthcare. The IntrepidGP discussion reflects growing practitioner demand for systematic frameworks to assess, compare, and govern multiple LLMs deployed across a health system's AI portfolio. ---
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.